Clarius Group, LLC Eli Lilly & CO Transaction History

Clarius Group, LLC

$1.4 Billion
Q3 2024

A detailed history of Clarius Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clarius Group, LLC holds 6,036 shares of LLY stock, worth $4.8 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

6,036

Previous 6,152 1.89%

Holding current value

$4.8 Million

Previous $5.57 Million 3.99%

% of portfolio

0.38%

Previous 0.4%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$772.14 - $960.02 $89,568 - $111,362	-116 Reduced 1.89%	6,036 $5.35 Million
Q2 2024 Jul 11, 2024	SELL	$724.87 - $909.04 $195,714 - $245,440	-270 Reduced 4.2%	6,152 $5.57 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $585,093 - $782,772	-988 Reduced 13.33%	6,422 $5 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $276,775 - $326,281	-527 Reduced 6.64%	7,410 $4.32 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $723,775 - $997,834	-1,665 Reduced 17.34%	7,937 $4.26 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $189,750 - $253,718	541 Added 5.97%	9,602 $4.5 Million
Q1 2023 Apr 17, 2023	SELL	$310.63 - $364.82 $256,269 - $300,976	-825 Reduced 8.35%	9,061 $3.11 Million
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $60,451 - $70,437	188 Added 1.94%	9,886 $3.62 Million
Q3 2022 Oct 24, 2022	BUY	$296.48 - $337.87 $120,370 - $137,175	406 Added 4.37%	9,698 $3.14 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $180,895 - $212,398	649 Added 7.51%	9,292 $3.01 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $48,117 - $59,714	214 Added 2.54%	8,643 $2.39 Million
Q3 2021 Oct 18, 2021	BUY	$221.6 - $272.71 $57,837 - $71,177	261 Added 3.2%	8,429 $1.95 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $33,040 - $42,737	-183 Reduced 2.19%	8,168 $1.88 Million
Q1 2021 Apr 27, 2021	BUY	$164.32 - $212.72 $150,681 - $195,064	917 Added 12.34%	8,351 $1.56 Million
Q4 2020 Jan 15, 2021	BUY	$130.46 - $172.63 $99,671 - $131,889	764 Added 11.45%	7,434 $1.26 Million
Q3 2020 Oct 09, 2020	SELL	$146.22 - $169.13 $74,279 - $85,918	-508 Reduced 7.08%	6,670 $987,000
Q2 2020 Jul 08, 2020	BUY	$136.42 - $164.18 $84,580 - $101,791	620 Added 9.45%	7,178 $1.18 Million
Q1 2020 Apr 24, 2020	BUY	$119.05 - $147.35 $68,453 - $84,726	575 Added 9.61%	6,558 $910,000
Q4 2019 Jan 22, 2020	BUY	$106.92 - $132.43 $28,868 - $35,756	270 Added 4.73%	5,983 $844,000
Q3 2019 Oct 23, 2019	SELL	$106.79 - $116.16 $34,920 - $37,984	-327 Reduced 5.41%	5,713 $639,000
Q2 2019 Aug 02, 2019	BUY	$110.79 - $129.32 $155,549 - $181,565	1,404 Added 30.28%	6,040 $669,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $258,127 - $303,835	2,319 Added 100.09%	4,636 $602,000
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $245,370 - $274,888	2,317 New	2,317 $268,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Eli Lilly & CO Transaction History